Cardiol Therapeutics Inc. is a leading biotechnology company specializing in the research and development of innovative pharmaceuticals derived from cannabidiol (CBD). With a focus on cardiovascular diseases, their revolutionary therapies have the potential to revolutionize patient care and improve outcomes.
